{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:06Z","timestamp":1792801686266,"version":"4.5.0"},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T00:00:00Z","timestamp":1187136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>It is well established that the commonly used recreational drugs 3,4\u2010methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) and para\u2010methoxyamphetamine (PMA) facilitate the release and prevent the reuptake of 5\u2010hydroxytryptamine (5\u2010HT, serotonin). Although these drugs have similar potencies for their abilities to increase the release and inhibit the re\u2010uptake of 5\u2010HT, PMA has greater potency as an inhibitor of monoamine oxidase (MAO)\u2010A.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The present study compared the abilities of PMA and MDMA to increase extracellular 5\u2010HT concentrations in animals with functional MAO\u2010A and when MAO\u2010A activity was inhibited by clorgyline.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Samples of extracellular fluid from rat substantia nigra were collected using microdialysis and then analysed for 5\u2010HT and 5\u2010hydroxyindol acetic acid (5\u2010HIAA) by high\u2010performance liquid chromatography coupled with electrochemical detection. The 5\u2010HT\u2010mediated effects on body temperature and behaviour were also recorded. Rats were pretreated with saline or 10\u00a0mg\/kg, i.p., clorgyline and, 24\u00a0h later, injected with 10\u00a0mg\/kg MDMA, PMA or saline.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Both MDMA and PMA produced significant increases in extracellular 5\u2010HT concentrations (482\u00a0\u00b1\u00a083 and 726\u00a0\u00b1\u00a0287%, respectively; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Rats treated with PMA and MDMA displayed significantly increased 5\u2010HT\u2010related behavours (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.05). Furthermore, only MDMA was capable of producing additional significant increases in 5\u2010HT concentrations (1033\u00a0\u00b1\u00a0131%; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.01) when coadministered with clorgyline.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The results of the present study suggest that PMA and MDMA are similar in their abilities to increase extracellular 5\u2010HT levels in animals with functional MAO\u2010A activity. However, coadministration of these substituted amphetamines with an MAO\u2010A inhibitor causes significant potentiation in the ability to increase extracellular levels of 5\u2010HT for MDMA, but not PMA.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04734.x","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T04:51:17Z","timestamp":1187326277000},"page":"1051-1057","source":"Crossref","is-referenced-by-count":12,"title":["POTENTIATION OF 3,4\u2010METHYLENEDIOXYMETHAMPHETAMINE\u2010INDUCED 5\u2010HT RELEASE IN THE RAT SUBSTANTIA NIGRA BY CLORGYLINE, A MONOAMINE OXIDASE A INHIBITOR"],"prefix":"10.1111","volume":"34","author":[{"given":"Ryan","family":"Hewton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230220119363"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05199.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106063268"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300896"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.55.3.3"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0322-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00126-3"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00711-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0149-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2001.tb143372.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120019130"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1971.tb12034.x"},{"issue":"2","key":"e_1_2_6_14_2","first-page":"S8","article-title":"Pharmacology of moclobemide","volume":"16","author":"Haefely W","year":"1993","journal-title":"Clin. Neuropharmacol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1994.26"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00405-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(00)00113-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00292.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.01.093"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.01.012"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90285-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67041532.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815526"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90805-0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890170102"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(94)90275-5"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(20000615)36:4<275::AID-SYN4>3.0.CO;2-#"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5400.401"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04182.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00177909"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(00)00179-2"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(03)02555-1"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00166940"},{"key":"e_1_2_6_34_2","first-page":"357","article-title":"The effects of brofaromine, a reversible MAO\u2010A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats","volume":"41","author":"Celada P","year":"1994","journal-title":"J. Neural. Transm. Suppl"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1980.tb12909.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-15-06385.2003"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90101-2"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04734.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04734.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:28:38Z","timestamp":1696872518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04734.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04734.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04734.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}